Tianjin Chase Sun Pharmaceutical Co Ltd (300026) - Total Liabilities

Latest as of March 2026: CN¥1.65 Billion CNY ≈ $241.01 Million USD

Based on the latest financial reports, Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has total liabilities worth CN¥1.65 Billion CNY (≈ $241.01 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Tianjin Chase Sun Pharmaceutical Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.

Tianjin Chase Sun Pharmaceutical Co Ltd - Total Liabilities Trend (2006–2024)

This chart illustrates how Tianjin Chase Sun Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 300026 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Tianjin Chase Sun Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Tianjin Chase Sun Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
DOMS Industries Limited NSE:DOMS	India	Rs4.21 Billion
Prudent Corporate Advisory Services Limited NSE:PRUDENT	India	Rs3.42 Billion
A.F.P. Habitat SN:HABITAT	Chile	CL$349.69 Billion
Shanghai Pret Composites SHE:002324	China	CN¥8.21 Billion
Jiangyin Jianghua Microelectronics Materials Co Ltd SHG:603078	China	CN¥748.09 Million
Xinjiang Machinery Research Inst SHE:300159	China	CN¥553.44 Million
Dynapack International Technology TWO:3211	Taiwan	NT$5.62 Billion
Weichai Heavy Machinery Co Ltd SHE:000880	China	CN¥5.69 Billion

Liability Composition Analysis (2006–2024)

This chart breaks down Tianjin Chase Sun Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Tianjin Chase Sun Pharmaceutical Co Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.70	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.19	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.16	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tianjin Chase Sun Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)

The table below shows the annual total liabilities of Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥2.37 Billion ≈ $346.30 Million	-20.24%
2023-12-31	CN¥2.97 Billion ≈ $434.20 Million	-28.80%
2022-12-31	CN¥4.17 Billion ≈ $609.88 Million	+14.03%
2021-12-31	CN¥3.65 Billion ≈ $534.83 Million	+31.11%
2020-12-31	CN¥2.79 Billion ≈ $407.94 Million	+105.55%
2019-12-31	CN¥1.36 Billion ≈ $198.46 Million	+49.43%
2018-12-31	CN¥907.61 Million ≈ $132.81 Million	-1.31%
2017-12-31	CN¥919.62 Million ≈ $134.57 Million	-26.00%
2016-12-31	CN¥1.24 Billion ≈ $181.84 Million	+5.07%
2015-12-31	CN¥1.18 Billion ≈ $173.07 Million	+72.69%
2014-12-31	CN¥684.85 Million ≈ $100.22 Million	+32.62%
2013-12-31	CN¥516.40 Million ≈ $75.57 Million	+24.38%
2012-12-31	CN¥415.19 Million ≈ $60.76 Million	+16.15%
2011-12-31	CN¥357.47 Million ≈ $52.31 Million	+96.26%
2010-12-31	CN¥182.14 Million ≈ $26.65 Million	+35.02%
2009-12-31	CN¥134.90 Million ≈ $19.74 Million	+47.22%
2008-12-31	CN¥91.63 Million ≈ $13.41 Million	-19.47%
2007-12-31	CN¥113.79 Million ≈ $16.65 Million	+34.91%
2006-12-31	CN¥84.34 Million ≈ $12.34 Million	--

About Tianjin Chase Sun Pharmaceutical Co Ltd

SHE:300026 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.50 Billion

CN¥10.27 Billion CNY

Market Cap Rank

#7118 Global

#1486 in China

Share Price

CN¥3.42

Change (1 day)

+1.48%

52-Week Range

CN¥2.90 - CN¥4.33

All Time High

CN¥9.11